Comevo Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Comevo's estimated annual revenue is currently $2.3M per year.(i)
  • Comevo's estimated revenue per employee is $101,500

Employee Data

  • Comevo has 23 Employees.(i)

Comevo's People

NameTitleEmail/Phone
1
VP Sales and Marketing/Business DevelopmentReveal Email/Phone
2
VP DevelopmentReveal Email/Phone
3
VP OperationsReveal Email/Phone
4
Director SalesReveal Email/Phone
5
UI/UX DeveloperReveal Email/Phone
6
Technical Support AssistantReveal Email/Phone
7
Senior Account ExecutiveReveal Email/Phone
8
SaaS System AdministratorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$53.9M2978%N/AN/A
#2
$17.9M1281%N/AN/A
#3
$1109.3M535012%$1.3BN/A
#4
$1510.7M4905N/AN/AN/A
#5
$15.1M104N/AN/AN/A
#6
$45.5M28544%N/AN/A
#7
$0.7M9N/AN/AN/A
#8
$0.5M7N/AN/AN/A
#9
$19.1M91N/AN/AN/A
#10
$4.8M4513%$1.8MN/A
#11
$2.7M27N/AN/AN/A
#12
$2.6M27N/AN/AN/A
#13
$0.1M4N/AN/AN/A
#14
$23.4M147N/AN/AN/A
#15
$9.8M135N/AN/AN/A
#16
$0.4M6N/AN/AN/A
#17
$0.6M8N/AN/AN/A
#18
$0.4M6N/AN/AN/A
#19
$1.4M16N/AN/AN/A
#20
$2.6M21N/AN/AN/A
Add Company

What Is Comevo?

keywords:N/A

N/A

Total Funding

23

Number of Employees

$2.3M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Comevo News

2022-04-17 - EVO VISIAN® ICL: An Evolutionary Vision Correction ...

Edward C. Wade, M.D., F.A.C.S. is the First Eye Surgeon in Houston and One of the First Doctors in Texas to Implant the EVO Visian ICL to...

2022-04-13 - Dr. Scott Perkins at Barnet Dulaney Perkins Eye Center is first ...

Perkins. To learn more about the EVO Visian ICL and whether you may be a candidate, please go to https://bdplasik.com/evo-visian-...

2022-03-22 - Evo 2022 lineup announced

Dragon Ball FighterZ, Mortal Kombat 11, Melty Blood: Type Lumina, Skullgirls 2nd Encore, Street Fighter V Champion Edition, Tekken 7, Guilty...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.3M230%N/A
#2
$5.3M23-4%N/A
#3
$3.5M24-8%N/A
#4
$5.5M24-37%N/A
#5
$2.9M24-8%N/A